© 1993 by European Society of Cardiology
Copyright © 1993, European Society of Cardiology
Cardiac angiotensin receptors in experimental hyperthyroidism in dogs
Department of Physiology and Pharmacology, University of Queensland, Queensland 4072, Australia: C Sernia, C Marchant, L Brown, A Hoey.
Correspondence to Dr Sernia.
Objective: The aim was to define the changes in angiotensin II receptors and the plasma renin-angiotensin system in experimental hyperthyroidism in dogs. Methods: Hyperthyroidism was induced in dogs by subcutaneous injection of triiodothyronine (T3; 1 mg·kg–1·d–1 for 14 d; group T); control dogs received saline (group C). Plasma angiotensin II (AII), angiotensinogen, renin activity and concentration, and angiotensin II receptors in left ventricle, right atrium, thoracic aorta, adrenal gland, and liver were measured. Results: T3 treatment caused tachycardia, increased heart weight, hypertrophy of the circumflex and septal coronary arteries, increased plasma renin activity [C=1.6(SEM 0.2), T=9.8(2.8) ng angiotensin I·ml–1·h–1], plasma renin concentration [C=13.0(3.7), T=34.5(5.6) ng angiotensin I·ml–1·h–1], and plasma AII [C=23(3), T= 104(5) pg·ml–1], while plasma angiotensinogen did not change. There were no significant changes in adrenal gland and right atrial angiotensin II receptor densities; increases were measured in the left ventricle [C=0.33(0.06), T=0.75(0.12) pmol·g–1 tissue], thoracic aorta [C=0.19(0.02), T=0.28(0.03) pmol·g–1 tissue], and liver [C=8.4(1.2), T=12.9(1.7) pmol·g–1 tissue]. The relative affinities of the left ventricular angiotensin II receptor for angiotensin peptides (obtained from displacement assays) were: Sar1, IIe8 AII > AII > angiotensin III > angiotensin I > hexapeptide > pentapeptide. Conclusions: Experimental hyperthyroidism in dogs results in activation of the plasma renin-angiotensin system and up regulation of left ventricular, aortic and liver angiotensin II receptors.
Cardiovascular Research 1993;27:423-428
KEYWORDS hyperthyroidism; renin-angiotensin; cardiac angiotensin receptors; cardiac hypertrophy
This work was supported by a grant from the National Health and Medical Research Council of Australia. We thank Mr Ross Bathgate for technical assistance.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C R Liu, L Y Li, F Shi, X Y Zang, Y M Liu, Y Sun, and B H Kan Effects of hyper- and hypothyroid on expression of thyroid hormone receptor mRNA in rat myocardium J. Endocrinol., December 1, 2007; 195(3): 429 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Carneiro-Ramos, G. P. Diniz, J. Almeida, R. L. P. Vieira, S. V. B. Pinheiro, R. A. Santos, and M. L. M. Barreto-Chaves Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism J. Physiol., August 15, 2007; 583(1): 213 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimoni, D. Hunt, K. Chen, T. Emmett, and G. Kargacin Differential autocrine modulation of atrial and ventricular potassium currents and of oxidative stress in diabetic rats Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1879 - H1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, L. C. Carey, N. K. Valego, J. Liu, and J. C. Rose Thyroid hormone modulates renin and ANG II receptor expression in fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1006 - R1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Volzke, D. M. Robinson, U. Schminke, J. Ludemann, R. Rettig, S. B. Felix, C. Kessler, U. John, and W. Meng Thyroid Function and Carotid Wall Thickness J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2145 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuyama, T. Ichiki, K. Takeda, T. Tokunou, N. Iino, S. Masuda, M. Ishibashi, K. Egashira, H. Shimokawa, K. Hirano, et al. Downregulation of Vascular Angiotensin II Type 1 Receptor by Thyroid Hormone Hypertension, March 1, 2003; 41(3): 598 - 603. [Abstract] [Full Text] [PDF] |
||||





